Trends: Assets
€ million |
|
2025 |
|
2024 |
|||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|||
Intangible assets, property, plant and equipment, investment property and right-of-use assets1 |
|
3,733.3 |
|
4,004.5 |
|||
Investments in joint ventures and associates accounted for using the equity method |
|
599.2 |
|
976.2 |
|||
Other noncurrent assets |
|
145.0 |
|
462.0 |
|||
Noncurrent assets |
|
4,477.5 |
|
5,442.7 |
|||
Inventories1 |
|
1,439.3 |
|
1,707.4 |
|||
Trade receivables |
|
689.0 |
|
764.6 |
|||
Other current assets |
|
1,765.2 |
|
1,495.2 |
|||
Current assets |
|
3,893.5 |
|
3,967.2 |
|||
Total assets |
|
8,371.0 |
|
9,409.9 |
|||
|
|||||||
Fixed assets down due to impairment losses and reduced investment spending
Relative to the previous year, fixed assets (including equity-accounted investments) dropped by €648.2 million to €4.33 billion (Dec. 31, 2024: €4.98 billion). Property, plant and equipment remained virtually constant at €3.20 billion (Dec. 31, 2024: €3.32 billion). Capital expenditures fell in 2025 to €465.9 million (2024: €709.4 million). Over half of the funds were invested in Germany. Right-of-use assets from leases amounted to €270.8 million as of the reporting date (Dec. 31, 2024: €273.2 million). Financing liabilities from leases amounted to €323.0 million (Dec. 31, 2024: €330.7 million). Depreciation/amortization amounted to €606.4 million (2024: €472.7 million). This includes impairment losses on goodwill in the Biosolutions division in the amount of €89.1 million. In 2025, a change in accounting policy meant that carbon credits were reclassified from inventories to intangible assets, as this is considered to facilitate a more relevant and clearer presentation of the facts. The figure came to €66.5 million as of December 31, 2025 with the prior-year figure being adjusted accordingly (December 31, 2024: €88.1 million).
As of December 31, 2025, €517.2 million was recognized in the statement of financial position for the equity-accounted investment in Siltronic AG (Dec. 31, 2024: €883.0 million). This includes the current investment income from Siltronic AG in the amount of €-28.7 million and an impairment loss of €307.8 million.
Noncurrent assets
Other noncurrent assets totaled €145.0 million as of December 31, 2025 (Dec. 31, 2024: €462.0 million), down by 68.6 percent year over year. This also reflects the impairment losses for deferred tax assets in Germany, which are no longer recoverable as a result of the loss incurred.
Working capital down 11 percent
Current assets came to €3.89 billion (Dec. 31, 2024: €3.97 billion), down by 1.9 percent year over year. The drop was due mainly to lower working capital, which fell by 11.4 percent to €1.44 billion (Dec. 31, 2024 : €1.62 billion).
Inventories were down by 15.7 percent to €.1.44 billion (Dec. 31, 2024: €1.71 billion), mainly as a result of a targeted inventory-reduction program. The decrease of 9.9 percent in trade receivables to €689.0 million (Dec. 31, 2024: €764.6 million), was due to lower sales. Lower sales and investment volumes meant that trade payables declined considerably too.
€ million |
|
2025 |
|
2024 |
|
Change |
|||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|||
Trade receivables |
|
689.0 |
|
764.6 |
|
-9.9 |
|||
Inventories1 |
|
1,439.3 |
|
1,707.4 |
|
-15.7 |
|||
Trade payables |
|
-692.3 |
|
-851.5 |
|
-18.7 |
|||
Working capital |
|
1,436.0 |
|
1,620.5 |
|
-11.4 |
|||
|
|||||||||
Liquidity at a high level of €1.48 billion
Securities, fixed-term deposits, and cash and cash equivalents are major components of other current assets. Current securities and fixed-term deposits amounted to €379.2 million as of December 31, 2025 (Dec. 31, 2024 : €167.6 million). Cash and cash equivalents came to €1.10 billion as of December 31, 2025 (Dec. 31, 2024: €1.05 billion). All in all, liquid assets (noncurrent and current securities, cash and cash equivalents) remained at a high level at €1.48 billion (Dec. 31, 2024: €1.26 billion). The dividend payment made by Wacker Chemie AG resulted in an outflow of liquid assets in the amount of €124.2 million (2024: €149.0 million). WACKER invested €553.2 million primarily in expanding its capacities (2024: €695.0 million).